Article Details

Research Shows Infusing Isatuximab in Just 30 Minutes Provides Same Safety

Retrieved on: 2025-02-20 19:41:19

Tags for this article:

Click the tags to see associated articles and topics

Research Shows Infusing Isatuximab in Just 30 Minutes Provides Same Safety. View article details on hiswai:

Excerpt

Isatuximab is an FDA-approved monoclonal antibody that targets the protein CD38 within cancer cells. It plays a role in regulating and maintaining ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo